Prosecution Insights
Last updated: April 19, 2026

Uniqure IP B.V.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17961097 GENE CONSTRUCTS FOR SILENCING ANGIOPOIETIN-LIKE 3 (ANGPTL3) AND USES THEREOF ANGELL, JON E 1637 Non-Final OA Oct 06, 2022
17751934 RNAI INDUCED HUNTINGTIN GENE SUPPRESSION ANGELL, JON E 1637 Final Rejection May 24, 2022
17323641 COMPANION DIAGNOSTIC TO MONITOR THE EFFECTS OF GENE THERAPY CHUNDURU, SURYAPRABHA 1681 Final Rejection May 18, 2021

Managing Uniqure IP B.V.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month